Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
IRegene Therapeutics Receives FDA RMAT Designation for NouvNeu001 in Parkinson’s Disease
Tuesday, January 20, 2026IRegene Therapeutics has announced that its lead product NouvNeu has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for the treatment of Parkinsons disease
Kelun-Biotech Showcases Innovative Achievements and Future Development Strategy at the 44th Annual J.P. Morgan Healthcare Conference
Friday, January 16, 2026Sichuan KelunBiotech presented its latest RD advancements commercialization successes and global expansion plans at the th JP Morgan Healthcare Conference on January
InterAx and Alveus Enter Strategic Research and Licensing Agreement for Metabolic Disease Therapy
Friday, January 16, 2026InterAx Biotech Ltd and Alveus Therapeutics Inc have entered into a strategic research collaboration and licensing agreement to develop a differentiated smallmolecule therapeutic candidate for metabolic disease
Zydus Lifesciences completes acquisition of Agenus biologics manufacturing assets and launches Zylidac Bio LLC in the US
Friday, January 16, 2026Zydus Lifesciences Limited has completed the acquisition of biologics manufacturing assets from Agenus Inc following the completion of all required regulatory approvals including clearance from the Committee
International Healthcare Week Returns to Thailand in 2026 with Expanded Industry Reach
Thursday, January 15, 2026International Healthcare Week returns to Thailand on July uniting pharmaceutical medical device and manufacturing sectors with over exhibitors and visitors
Celltrion Presents Innovative Drug Pipeline and U.S. Manufacturing and R&D Expansion Strategy at 44th J.P. Morgan Healthcare Conference
Wednesday, January 14, 2026South Korean biopharma leader Celltrion announced plans for IND submissions by and US manufacturing expansion at the JP Morgan Healthcare Conference
Lynk Pharmaceuticals reports positive Phase III topline data for JAK1 inhibitor zemprocitinib in rheumatoid arthritis, advancing Greater China immunology strategy
Monday, January 12, 2026Lynk Pharmaceuticals has announced positive Phase III topline results in China for its selective JAK inhibitor zemprocitinib in rheumatoid arthritis reinforcing its immunology pipeline and commercialization partnership with Simcere in Greater China
China SXT Pharmaceuticals launches AI insights initiative to modernize traditional Chinese medicine portfolio and market strategy
Friday, January 09, 2026China SXT Pharmaceuticals has launched a strategic AI insights initiative to optimize its traditional Chinese medicine product portfolio modernize RD decisionmaking and enhance market and clinic deployment across China
Alessa Therapeutics Receives FDA Fast Track Status for Enolen in Localised Prostate Cancer
Friday, January 09, 2026Alessa Therapeutics a clinicalstage biopharmaceutical company developing local drug delivery technologies for earlystage prostate cancer has received Fast Track designation from the US Food and Drug Administration for Enolen
BeOne Medicines Reports Positive Phase 3 HERIZON-GEA-01 Results for ZIIHERA Plus TEVIMBRA in HER2-Positive Advanced Gastric and Gastroesophageal Adenocarcinoma, Targeting Asian Regulatory Fil
Thursday, January 08, 2026BeOne Medicines has reported positive Phase HERIZONGEA results for ZIIHERA plus TEVIMBRA and chemotherapy in HERpositive advanced gastric and gastroesophageal adenocarcinoma and plans regulatory submissions in China and other Asian markets
